The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Carina Biotech
Adelaide, Australia
A
1-10 Employees
2016
Key takeaway
Carina Biotech is at the forefront of developing next-generation CAR-T cell therapies that harness the patient's immune system to combat cancer, offering a promising new treatment option.
Reference
Core business
Carina Biotech | Fighting Cancer with CAR-T Technologies | Australia
Carina Biotech are creating a future that defeats cancer. Empowering patients to fight cancer through next-generation CAR-T therapies. Find out more.
CELL THERAPIES PTY LTD
Melbourne, Australia
A
11-50 Employees
2002
Key takeaway
Cell Therapies is a contract development and manufacturing organization (CDMO) that specializes in the manufacturing and delivery of advanced cell-based therapies, including CAR-T cell therapy. With over 20 years of GMP manufacturing experience and licenses from the Australian Therapeutic Goods Administration, they ensure that their products meet global regulatory standards, offering significant advantages for clinical trial and commercial supply.
Reference
Core business
Cell Therapies | GMP Manufacturing of cell and gene therapies
Groundbreaking cell and gene therapy manufacturing and commercialization cell therapies is an Australian-based, globally-active commercial contract developm ...
Myrio Tx
Melbourne, Australia
A
11-50 Employees
2009
Key takeaway
Myrio Therapeutics is focused on developing innovative antibody-based therapies that target proteins inside cells, including those associated with cancer. Their advanced antibody discovery platform, Retained DisplayTM (ReD), positions them at the forefront of immuno-oncology.
Reference
Core business
About Us - Myrio Tx
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Haemalogix
Sydney, Australia
A
1-10 Employees
-
Key takeaway
HaemaLogiX is actively developing CAR-T cell therapies that specifically target unique antigens on malignant bone marrow cells, aiming to improve treatment outcomes for patients with blood cancers like multiple myeloma. Their team's expertise in immunotherapy and monoclonal antibodies underpins this innovative approach to combating hematological malignancies.
Reference
Product
Technology | HaemaLogiX
Following the discovery of two unique antigens on malignant Bone Marrow Cells, HaemaLogiX is developing Monoclonal Antibodies, CAR T cell Therapies and Bispecific Antibodies that specifically target those malignant cells.
Cartago Biotech Pty Ltd
Sydney, Australia
A
1-10 Employees
2020
Key takeaway
Cartago Biotech is focused on innovative approaches in tissue regeneration, which may have implications for enhancing the quality of life for patients with chronic conditions.
Reference
Product
Cartago Biotech Pty Ltd - Chronic Back Pain, Tissue Regeneration
Better quality of life
EnGeneIC
Sydney, Australia
A
11-50 Employees
2000
Key takeaway
EnGeneIC is a clinical-stage biopharmaceutical company that develops targeted anti-cancer therapies using its proprietary EDV™ nanocell platform. This innovative platform enhances the potency of cancer treatments while reducing toxicity and stimulating a robust anti-tumor immune response.
Reference
Product
Technology - EnGeneIC
TechnologyEnGeneIC is a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform that enables current cancer treatments to be more potent and far less toxic, while also stimulating a potent anti-tumor immune response.EDV … Continue reading →
AUCENTRA THERAPEUTICS PTY LTD
Adelaide, Australia
A
11-50 Employees
-
Key takeaway
Aucentra Therapeutics is focused on developing innovative anti-cancer drugs, with a strong pipeline that includes candidates for treating leukemia and other aggressive cancers. Their expertise in small molecule drug discovery positions them to address significant unmet medical needs in cancer treatment.
Reference
Core business
Aucentra | Cancer Therapeutics
TGR BioSciences
Adelaide, Australia
A
11-50 Employees
2001
Key takeaway
TGR BioSciences specializes in innovative solutions for cell-based research applications, making it relevant for advancements in therapies like CAR-T cell therapy. Their patented CaptSure™ technology enhances the performance and efficiency of immunoassays, which could be instrumental in the research and development of cell therapies.
Reference
Core business
TGR BioSciences
Prorenata Biotech
Gold Coast City, Australia
A
1-10 Employees
2021
Key takeaway
Prorenata Biotech specializes in genetic medicine and innovative approaches like CRISPR and Lipid Nanoparticles, aiming to accelerate the development of gene-based therapeutics and vaccines. Their mission focuses on making advanced treatments more accessible to researchers and healthcare providers, ultimately benefiting those with unmet health needs.
Reference
Core business
Nanomedicine - LNPs & Genetic Medicine - Prorenata Biotech
We are experts in Lipid Nanoparticles and Gene Editing using CRISPR. We will ensure your molecule reaches its full potential!
Clarity Pharmaceuticals
Sydney, Australia
A
11-50 Employees
2010
Key takeaway
Clarity is a clinical-stage radiopharmaceutical company focused on developing next-generation theranostic products that enhance treatment outcomes for cancer. Their innovative Targeted Copper Theranostics (TCT) approach offers high accuracy and precision in treating various cancers, including significant indications like prostate and breast cancer, as well as rare types like neuroendocrine tumors and neuroblastoma.
Reference
Core business
Copper-Based Radiopharmaceutical Therapies and Diagnostics - Clarity
Clinical stage radiopharmaceutical company developing next-generation theranostic (therapy and diagnostic) products for children and adults with cancer
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T cell therapy industry in Australia, several key considerations emerge. Firstly, regulatory compliance is crucial, as the Therapeutic Goods Administration (TGA) governs the approval and monitoring of cellular therapies. Understanding the clinical trial landscape is also essential, as advancements in CAR-T therapies often stem from successful trials that address specific hematological malignancies. The competitive landscape features both established pharmaceutical companies and innovative biotech firms, necessitating thorough research on their pipelines and partnerships. Moreover, the challenges of high treatment costs and access to therapies can impact market dynamics and patient outcomes. Opportunities exist for collaboration between research institutions and industry players, particularly in developing next-generation therapies with improved efficacy and safety profiles. Environmental concerns related to the manufacturing processes and waste management in the biotech sector are increasingly relevant, prompting companies to adopt sustainable practices. Additionally, the global market relevance of CAR-T therapies highlights Australia's potential role as a research and development hub, contributing to global advancements in this field. Overall, a comprehensive understanding of these factors will provide valuable insights for anyone interested in the CAR-T cell therapy industry in Australia.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Australia |
| Amount of fitting manufacturers | 115 |
| Amount of suitable service providers | 113 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2000 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CAR-T Cell Therapy?
Start-Ups who are working in CAR-T Cell Therapy are Prorenata Biotech
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are Biotechnology, Other, IT, Software and Services, Healthcare, Medical
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
